Jingjia subsidiary receives tobacco production license for electronic cigarettes

Aug.08.2022
Jinjia Holdings' subsidiary received a tobacco production license for electronic cigarettes, expanding their capabilities in the industry.

On the evening of August 4, Jingjia Co., Ltd. (002191) announced that its controlling subsidiary, Shenzhen Yunpu Xinghe Technology Service Co., Ltd. (hereinafter referred to as "Yunpu Xinghe"), received a tobacco monopoly production enterprise license (OEM) issued by the State Tobacco Monopoly Administration.


It is understood that Yunpuxinghe mainly provides one-stop production and processing, assembly and supply chain services for electronic cigarette brand customers. Currently, they operate in a 20,000 square-meter research and production facility located in the Jingjia Industrial Park in Shenzhen.


Jingjia Corporation announced that in the future, Yunpuxinghe will rely on the accumulated advantages of resources, technology, team, and other comprehensive advantages to provide electronic cigarette and pod production and processing services to customers. This will have a positive impact on advancing the development of the new tobacco industry and the future production and operation of the company.


This is the second license obtained by Jinjia as of now. In July, another subsidiary company of Jinjia, Yunnan Yunshuo Technology Co., Ltd. ("Yunshuo Technology"), received a tobacco monopoly production enterprise license (aerosol) from the State Tobacco Monopoly Administration. As one of the first companies in Yunnan Province to obtain a tobacco monopoly production enterprise license (aerosol production enterprise), Yunshuo Technology will expand the research and development, production and sales of electronic cigarette e-liquid and other products within the scope of this license.


As we enter August, there is less than two months left until the end of the transition period for new regulations on electronic cigarettes. The issuance of tobacco production licenses has become increasingly frequent, and it appears that Jianjia Holdings may also receive a license in the near future.


It is understood that Jing Jia Group has laid out its involvement in the entire platform of the new tobacco industry chain.


Upstream, there is a strategic focus on vape oil, heat-not-burn (HNB) flavors and fragrances, and new materials with two companies in this space - Yunshuo Technology and Changyi Technology. Yunshuo Technology is primarily involved in the research and development, production, and sales of traditional tobacco flavors and fragrances, as well as vape oil with a client base that includes several Chinese tobacco companies. Changyi Technology has carved out a stake in the HNB flavors and fragrances sector, as well as related new materials.


In the midstream sector, there are several companies providing original design manufacturing (ODM) services for renowned domestic and international electronic cigarette brands. Some major players in this market include Jingjia Technology, which specializes in ODM/OEM production, as well as Yunpu Xinghe and several others.


In downstream news, FOOGO (Innovation Flavors Technology), a new tobacco brand, has been achieving positive reviews and making strides in market expansion with its electronic cigarette products. Meanwhile, Yunpu Xinghe in Shenzhen and Indonesia is providing a new tobacco supply chain service for customers domestically and overseas. Hong Kong's Hengtian Commercial is primarily responsible for tobacco and related products in import/export trade and overseas promotion.


Jingjia Corporation and several of its subsidiary companies are in the process of applying for various licenses. Currently, they have obtained licenses for producing vaporized substances and manufacturing electronic cigarettes through subcontractors. If their brand license application is approved, Jingjia Corporation will become the first listed company with complete involvement in the electronic cigarette industry chain.


Jiangjia Corporation announced that it is continually improving its service chain in the industry to offer clients a range of services including tobacco extracts, flavorings, ODM, assembly, import and export, customs clearance and logistics. The company is committed to becoming a comprehensive service provider in the tobacco related industry, possessing advanced design and research and development techniques, excellent production and manufacturing capabilities, and complete service capacity.


With the implementation of domestic e-cigarette policy measures being steadily promoted, the industry policies are becoming clearer, and the e-cigarette industry in China has officially entered a new era of regulated development with established rules.


Tianfeng Securities believes that the regulatory policies are raising industry barriers by directly setting standards for electronic cigarettes, increasing the difficulties in product research and development and production. Companies engaged in the electronic cigarette business must obtain approval from the tobacco monopoly administrative authorities. Leading companies will have an advantage in future industry development, benefiting from the growth of the industry, and there is a possibility for a continued dominance by a small number of strong brands and producers.


Jingjia Technology, which has a complete industrial chain, is expected to take a leading position in the new market.


This article has quoted or reprinted information from third-party sources, and the copyright belongs to the original media and author. If there is any infringement, please contact us to delete it. Any organization or individual who wishes to reprint it, please contact the author and do not re-post directly.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
Turning Point Brands said Executive Chairman David E. Glazek will become CEO on October 1, replacing Graham Purdy, who is stepping down for personal reasons. The company narrowed its 2026 adjusted EBITDA outlook to $70 million-$80 million from $70 million-$90 million while maintaining Modern Oral gross sales guidance of $330 million-$350 million and net sales guidance of $260 million-$270 million. In the second quarter, Modern Oral net sales rose 128% to $68.4 million and accounted for 48% of company-wide net sales. Adjusted EBITDA fell 50% year over year. TPB shares closed about 10% lower on September 21.
Market
Sep.22 by 2Firsts Perspectives
JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
Japan Tobacco International's Irish business has proposed a €0.25 tax increase on a pack of 20 cigarettes in its pre-Budget 2027 submission, below the €0.50-or-more increases typically imposed in recent Irish budgets. JTI says the proposal could generate around €45 million in additional Exchequer revenue while limiting further movement toward illicit and non-Irish-tax-paid tobacco. Revenue's existing estimate for a comparable €0.25 increase, including pro-rata rises on other tobacco products, is about €18 million for a full year.
JTI
Sep.18 by 2Firsts Perspectives
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
Russia’s Vape Device Labeling Regime Enters Force: Registration Starts in September, Mandatory Coding in December
Russia’s Vape Device Labeling Regime Enters Force: Registration Starts in September, Mandatory Coding in December
Russia's digital labeling regime for reusable e-cigarettes and similar personal vaping devices entered its first mandatory phase in September 2026. From September 1, manufacturers, importers and other market participants must register with the national Chestny ZNAK tracking system. From December 1, newly manufactured and imported covered devices will be required to carry digital identification codes and be reported as entering circulation. Russia has also issued new operational guidance for imports, marking the transition from a voluntary pilot to phased mandatory implementation.
Sep.15
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
French vaping company Kumulus Vape reported first-half 2026 revenue of €25.5 million, down 8.3% year over year, as its core B2B distribution business fell 11% to €21.6 million. B2C and store-network revenue rose 5.6% and 17.8%, respectively. Commercial margin increased to 26.3% from 21.7%, while net profit rose 24.1% to €0.8 million. The company attributed the profitability improvement to catalog optimization, logistics restructuring and the ramp-up of Labster, its in-house production unit for proprietary brands.
Market
Sep.17 by 2Firsts Perspectives
How Many Nicotine Pouch Factories Does Europe Need? 2Firsts Interviews AIRSCREAM on the OEM Market
How Many Nicotine Pouch Factories Does Europe Need? 2Firsts Interviews AIRSCREAM on the OEM Market
At InterTabac 2026, nicotine pouch growth was visible not only in brands but across equipment, raw materials and OEM manufacturing. 2Firsts interviewed AIRSCREAM commercial head Steve Moore on how many pouch factories Europe may ultimately need and where manufacturers can differentiate, from formulation and flavour to pouch materials, production consistency and customer service. The category continues to expand, but questions remain over future capacity, consolidation and the long-term structure of the supply chain.
Sep.18